Ankit K. Desai

732 total citations
30 papers, 503 citations indexed

About

Ankit K. Desai is a scholar working on Physiology, Organic Chemistry and Rheumatology. According to data from OpenAlex, Ankit K. Desai has authored 30 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 14 papers in Organic Chemistry and 12 papers in Rheumatology. Recurrent topics in Ankit K. Desai's work include Lysosomal Storage Disorders Research (24 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Glycogen Storage Diseases and Myoclonus (11 papers). Ankit K. Desai is often cited by papers focused on Lysosomal Storage Disorders Research (24 papers), Carbohydrate Chemistry and Synthesis (14 papers) and Glycogen Storage Diseases and Myoclonus (11 papers). Ankit K. Desai collaborates with scholars based in United States, Israel and Switzerland. Ankit K. Desai's co-authors include Priya S. Kishnani, Zoheb B. Kazi, Amy S. Rosenberg, Laura E. Case, Cindy Li, Harrison N. Jones, Stephanie Austin, Lisa D. Hobson‐Webb, Deeksha Bali and Punita Gupta and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Journal of Neuropathology & Experimental Neurology.

In The Last Decade

Ankit K. Desai

29 papers receiving 497 citations

Peers

Countries citing papers authored by Ankit K. Desai

Since Specialization

Citations

This map shows the geographic impact of Ankit K. Desai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ankit K. Desai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ankit K. Desai more than expected).

Fields of papers citing papers by Ankit K. Desai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ankit K. Desai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ankit K. Desai. The network helps show where Ankit K. Desai may publish in the future.

Co-authorship network of co-authors of Ankit K. Desai

This figure shows the co-authorship network connecting the top 25 collaborators of Ankit K. Desai. A scholar is included among the top collaborators of Ankit K. Desai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ankit K. Desai. Ankit K. Desai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing clinical outcomes: The journey of twins with CRIM-negative infantile-onset Pompe disease on high-dose enzyme replacement therapy and immunomodulation 2024 ·Molecular Genetics and Metabolism Reports ·(unknown), Ankit K. Desai, Laura E. Case, (unknown), (unknown), Amelia Kirby, (unknown), (unknown), Priya S. Kishnani	2
2	Optimizing treatment outcomes: immune tolerance induction in Pompe disease patients undergoing enzyme replacement therapy 2024 ·Frontiers in Immunology ·(unknown), Rai‐Hseng Hsu, (unknown), Ankit K. Desai, Ni‐Chung Lee, Wuh‐Liang Hwu, Fuu‐Jen Tsai, Priya S. Kishnani, Yin‐Hsiu Chien	7
3	An updated management approach of Pompe disease patients with high-sustained anti-rhGAA IgG antibody titers: experience with bortezomib-based immunomodulation 2024 ·Frontiers in Immunology ·Ankit K. Desai, Garima Shrivastava, Christina Grant, Raymond Wang, Trevor D. Burt, Priya S. Kishnani	5
4	Outside the fiber: Endomysial stromal and capillary pathology in skeletal muscle may impede infusion therapy in infantile-onset Pompe disease 2023 ·Journal of Neuropathology & Experimental Neurology ·Anne F. Buckley, Ankit K. Desai, (unknown), (unknown), (unknown), (unknown), Edward H. Bossen, Priya S. Kishnani	1
5	Successful AAV8 readministration: Suppression of capsid‐specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease 2023 ·The Journal of Gene Medicine ·Su Jin Choi, John S. Yi, Jeong‐A Lim, Thomas F. Tedder, Dwight D. Koeberl, William R. Jeck, Ankit K. Desai, Amy S. Rosenberg, Baodong Sun, Priya S. Kishnani	11
6	Development of high sustained anti-drug antibody titers and corresponding clinical decline in a late-onset Pompe disease patient after 11+ years on enzyme replacement therapy 2023 ·Molecular Genetics and Metabolism Reports ·Katherine H. Kim, Ankit K. Desai, (unknown), (unknown), Priya S. Kishnani, Barbara K. Burton	5
7	Immune modulation therapy for enzyme replacement therapy-treated Pompe disease patients 2023 ·Molecular Genetics and Metabolism ·(unknown), Rai‐Hseng Hsu, Ankit K. Desai, Ni‐Chung Lee, Wuh‐Liang Hwu, Priya S. Kishnani, Yin‐Hsiu Chien	0
8	A favorable outcome in an infantile-onset Pompe patient with cross reactive immunological material (CRIM) negative disease with high dose enzyme replacement therapy and adjusted immunomodulation 2022 ·Molecular Genetics and Metabolism Reports ·(unknown), Ankit K. Desai, Daniel Fink, (unknown), Priya S. Kishnani, Ronen Spiegel	9
9	Transforming the clinical outcome in CRIM-negative infantile Pompe disease identified via newborn screening: the benefits of early treatment with enzyme replacement therapy and immune tolerance induction 2021 ·Genetics in Medicine ·Cindy Li, Ankit K. Desai, Punita Gupta, (unknown), Vikas Bhambhani, Robert J. Hopkin, Can Fıçıcıoğlu, Pranoot Tanpaiboon, William J. Craigen, Amy S. Rosenberg, Priya S. Kishnani	33
10	Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease 2021 ·Frontiers in Immunology ·Anne S. De Groot, Ankit K. Desai, (unknown), S. M. Shahjahan Miah, Frances Terry, (unknown), Cindy Li, John S. Yi, Matt Ardito, William Martin, Priya S. Kishnani	14
11	A Race Against Time—Changing the Natural History of CRIM Negative Infantile Pompe Disease 2020 ·Frontiers in Immunology ·Punita Gupta, Brian J. Shayota, Ankit K. Desai, (unknown), (unknown), John Messina, (unknown), (unknown), Priya S. Kishnani	7
12	Immune Modulation for Enzyme Replacement Therapy in A Female Patient With Hunter Syndrome 2020 ·Frontiers in Immunology ·(unknown), (unknown), Laura Pollard, Holly Miller, Ankit K. Desai, Kristin Lindstrom, Priya S. Kishnani	12
13	Benefits of Prophylactic Short-Course Immune Tolerance Induction in Patients With Infantile Pompe Disease: Demonstration of Long-Term Safety and Efficacy in an Expanded Cohort 2020 ·Frontiers in Immunology ·Ankit K. Desai, (unknown), John W. Sleasman, Amy S. Rosenberg, Priya S. Kishnani	28
14	The potential impact of timing of IVIG administration on the efficacy of rituximab for immune tolerance induction for patients with Pompe disease 2020 ·Clinical Immunology ·Ankit K. Desai, Amy S. Rosenberg, Priya S. Kishnani	2
15	Pulmonary outcome measures in long‐term survivors of infantile Pompe disease on enzyme replacement therapy: A case series 2020 ·Pediatric Pulmonology ·Mai K. ElMallah, Ankit K. Desai, (unknown), Stephanie DeArmey, Richard M. Kravitz, Priya S. Kishnani	11
16	Improved muscle function in a phase I/II clinical trial of albuterol in Pompe disease 2019 ·Molecular Genetics and Metabolism ·Dwight D. Koeberl, Laura E. Case, Ankit K. Desai, Edward C. Smith, (unknown), Sang-oh Han, Beth L. Thurberg, Sarah P. Young, Deeksha Bali, Priya S. Kishnani	13
17	Immunological challenges and approaches to immunomodulation in Pompe disease: a literature review 2019 ·Annals of Translational Medicine ·Ankit K. Desai, Cindy Li, Amy S. Rosenberg, Priya S. Kishnani	44
18	High dose IVIG successfully reduces high rhGAA IgG antibody titers in a CRIM-negative infantile Pompe disease patient 2017 ·Molecular Genetics and Metabolism ·(unknown), Zoheb B. Kazi, Ankit K. Desai, (unknown), Amy S. Rosenberg, Priya S. Kishnani	11
19	The emerging phenotype of late-onset Pompe disease: A systematic literature review 2016 ·Molecular Genetics and Metabolism ·(unknown), Ankit K. Desai, Zoheb B. Kazi, (unknown), Stephanie Austin, Lisa D. Hobson‐Webb, Laura E. Case, Harrison N. Jones, Priya S. Kishnani	131
20	158 Chronic urticaria in patients with high titer antimicrosomal antibodies 1983 ·Journal of Allergy and Clinical Immunology ·Ankit K. Desai, Steven H. Young, Bernard R. Adelsberg, Debra Bergman	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact